03.07.12
A clinical trial published revealed daily dosing of Calzbone extract from Verdure Sciences significantly improved bone density (BMD) in women.
Data from the 26-week clinical study on 40 middle-aged, healthy women aged 45-55 showed that 250 mg of Calzbone extract thrice daily led to significant improvement in bone density of 18% (p<0.01) from baseline, a significant lowering of T-score and Z-score (p<0.01) as well as a decrease of serum alkaline phosphatase and serum tartrate resistant acid phosphatase (p<0.001). These findings together suggest strong potential for the use of Calzbone to support bone strength and healthy bone density.
In the peer-reviewed publication in The Antiseptic, the authors also remarked that Calzbone was well-tolerated and also clinically improved signs of joint swelling, pain and stiffness present in some subjects with co-existing osteoarthritis. For further information: www.vs-corp.com
Data from the 26-week clinical study on 40 middle-aged, healthy women aged 45-55 showed that 250 mg of Calzbone extract thrice daily led to significant improvement in bone density of 18% (p<0.01) from baseline, a significant lowering of T-score and Z-score (p<0.01) as well as a decrease of serum alkaline phosphatase and serum tartrate resistant acid phosphatase (p<0.001). These findings together suggest strong potential for the use of Calzbone to support bone strength and healthy bone density.
In the peer-reviewed publication in The Antiseptic, the authors also remarked that Calzbone was well-tolerated and also clinically improved signs of joint swelling, pain and stiffness present in some subjects with co-existing osteoarthritis. For further information: www.vs-corp.com
